ERBITUX SOLN FOR INF: 66 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
66
Total FAERS Reports
6 (9.1%)
Deaths Reported
24
Hospitalizations
66
As Primary/Secondary Suspect
5
Life-Threatening
4
Disabilities
First Report: 2008 · Latest Report: 20140510
What Are the Most Common ERBITUX SOLN FOR INF Side Effects?
#1 Most Reported
Rash
7 reports (10.6%)
#2 Most Reported
Infusion related reaction
5 reports (7.6%)
#3 Most Reported
Hypersensitivity
5 reports (7.6%)
All ERBITUX SOLN FOR INF Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Rash | 7 | 10.6% | 0 | 1 |
| Hypersensitivity | 5 | 7.6% | 0 | 1 |
| Infusion related reaction | 5 | 7.6% | 1 | 1 |
Who Reports ERBITUX SOLN FOR INF Side Effects? Age & Gender Data
Average age: 63.5 years. Most reports from: DE. View detailed demographics →
Is ERBITUX SOLN FOR INF Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2008 | 1 | 0 | 0 |
| 2009 | 1 | 0 | 1 |
| 2012 | 5 | 1 | 2 |
| 2013 | 24 | 2 | 6 |
| 2014 | 20 | 2 | 14 |
What Is ERBITUX SOLN FOR INF Used For?
| Indication | Reports |
|---|---|
| Colorectal cancer metastatic | 9 |
| Colon cancer | 8 |
| Head and neck cancer | 7 |
Official FDA Label for ERBITUX SOLN FOR INF
Official prescribing information from the FDA-approved drug label.